Long Non-Coding RNA CRYBG3 Promotes Lung Cancer Metastasis via Activating the eEF1A1/MDM2/MTBP Axis

Anqing Wu1,2, Jiaxin Tang1,2, Ziyang Guo1,2

  • 1State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, China.

Insights

A novel long non-coding RNA (lncRNA), LNC CRYBG3, promotes non-small cell lung cancer (NSCLC) metastasis by regulating the eEF1A1/MDM2/MTBP/ACTN4 pathway. This discovery offers a potential new therapeutic target for NSCLC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Distant tumor metastases significantly impede non-small cell lung cancer (NSCLC) treatment and patient outcomes.
  • Long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of metastasis in lung cancer.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of the novel long non-coding RNA (lncRNA) LNC CRYBG3 in regulating NSCLC metastasis.

Main Methods:

  • Quantitative analysis of LNC CRYBG3 expression in NSCLC cells versus normal tissues.
  • In vitro experiments involving overexpression of LNC CRYBG3 in HCC827 cells to assess metastatic potential and protein expression.
  • In vivo metastasis assays.
  • Mechanistic studies to elucidate the interaction of LNC CRYBG3 with eEF1A1, MDM2, MTBP, and ACTN4.

Main Results:

  • LNC CRYBG3 was found to be upregulated in NSCLC cells and correlated with metastatic ability.
  • Overexpression of LNC CRYBG3 enhanced metastasis and increased Snail and Vimentin protein levels in HCC827 cells, both in vitro and in vivo.
  • LNC CRYBG3 directly binds to eEF1A1, promoting nuclear translocation and enhancing MDM2 transcription. This leads to MDM2/MTBP complex formation, disrupting MTBP/ACTN4 binding and increasing cell migration.

Conclusions:

  • The LNC CRYBG3/eEF1A1/MDM2/MTBP axis represents a newly identified signaling pathway crucial for regulating tumor metastasis in NSCLC.
  • LNC CRYBG3 emerges as a potential therapeutic target for managing NSCLC metastasis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K